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Background: The presence of tumor supporting cells in various cancer, including in hepatocellular carcinoma
(HCC), has become an important target in the study of carcinogenesis. The cancer-associated fibroblast (CAF), one
of the most important cellular components in the cancer stroma, might contribute to the progression of the disease
due to its plasticity, a behavior of the stem cells. In this study, we investigate the significance of the CAF and its role
in the HCC progression and metastasis.
Methods: Primary CAF and non-tumoral fibroblast (NTF) from nine paired HCC and distant non-tumoral liver tissues
were isolated and cultured. The cells were characterized by flow cytometry, RT-PCR, anchorage-independent assay
and in vitro cells directed trans-differentiation. Co-culture study was performed in Transwell system and xenograft
assay was performed in immunodeficient mice.
Results: CAF and NTF were positive for CD90, CD44, αSMA, and vimentin and negative for CD34, CD45, CD117, and
CD133. When stimulated, they showed the potential to differentiate into adipocytes, osteoblasts, and pancreatic
cells. When co-cultured with human HCC cell lines, CAF up-regulated gene expressions of TGFB1 and FAP of HuH-7
and JHH-6 while NTF did not induced either of the genes. Xenograft assay showed that the CAF had the capacity
to enter into circulation as confirmed by RT-PCR and DNA sequencing.
Conclusion: Our data provides evidence of the plasticity of the CAF and the NTF as stem cells in the process of
hepatocarcinogenesis and metastasis. These cells mutually interacts with HCC cells. Their trans-differentiation flexibility
may induce a switch from normal to cancerous microenvironment.
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MicroenvironmentBackground
Liver cancer is the fifth most common cancer in men
and the ninth in women, and the second most common
cause of cancer-related death, estimated to be respon-
sible for around 9% of all cases in 2012 [1]. Hepatocellu-
lar carcinoma (HCC) accounts for 85% to 90% of liver
cancer cases [2].
Recent studies had shown the importance of the cross
talk between cancer cells and their stromal microenvir-
onment, including in the HCC. The cancer-associated
fibroblast (CAF), sometimes acknowledged as cancer stro-
mal cell, is the most important cell type in the stroma.* Correspondence: caecilia.sukowati@csf.units.it
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unless otherwise stated.Previously, Mazzocca et al. had demonstrated an inter-
action between CAF and HCC cells. The CAF appeared
essential for tumor growth and metastasis and the HCC
cells stimulated the proliferation of the CAF. HCC inva-
sive cells produced high levels of the connective tissue
growth factor (CTGF) and generated tumor with high
stromal component in vivo. The use of transforming
growth factor beta (TGFB) inhibitor was shown to inhibit
tumor specific neoangiogenesis and to interrupt their
cross talk, thus inhibiting tumor progression [3,4]. Inter-
estingly, CAF-like myofibroblastic phenotype can be origi-
nated from peritumoral tissue fibroblasts (PTF) in the
presence of lysophostatidic acid (LPA) secreted by HCC
cells [5].
Due to its cellular heterogeneity and various physio-
logical functions of the liver, the cellular origin of theal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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different sources such as resident fibroblast, migrated
bone-marrow stem cell, or epithelial-mesenchymal tran-
sition (EMT). Previously, it had been demonstrated that
the CAF in HCC have the characteristics of the multipo-
tent resident progenitor cells through a paracrine mech-
anism [6].
Despite mounting evidences on the effect of the CAF
in the disease progression in other cancers, its role in
hepatocarcinogenesis is still undefined. In this paper, we
report the potential of the stem cells-like fibroblasts present
in HCC and cirrhotic liver tissue to trans-differentiate into
other cell types. Data shows that this cell population plays
an important role in the maintenance and the progression
of liver disease.
Methods
Ethics
For human samples, written informed consent was ob-
tained from patient or by a legal representative and pa-
tient anonymity has been preserved. Investigation was
conducted according to the principles expressed in the
Declaration of Helsinki. For animal study, the experi-
mental procedure study was carried out in strict accord-
ance with the recommendations in the Guide for the
Care and Use of Laboratory Animals and all efforts were
made to minimize suffering. The Ethical Committee
Ateneo of the University of Trieste and responsible ad-
ministration of the Ministry of Health of the Republic of
Italy approved the protocol (Permit number: 107/2010).
Primary cells isolation
Paired fresh HCC and distant cirrhotic liver tissues were
obtained from nine HCC patients undergoing partial hep-
atic resection. The ratio of female:male was 5:4, mean age
73 ± 7 years; three were hepatitis C virus (HCV) positive
and six were metabolic-related HCC. None of the patients
received previous liver surgery, radiofrequency, and trans-
arterial chemoembolization.
Tissues were finely minced with scalpel in a tissue cul-
ture dish and enzymatically dissociated in 1 mg/mL col-
lagenase type IV (Sigma-Aldrich, St Louis, MO, USA) at
37°C for 1 hour with frequent shaking. The activity of
collagenase was blocked using phosphate saline buffer
(PBS) supplemented with 10% fetal bovine serum (FBS).
Single cells suspension was washed and filtered through
a 40 μm cell strainer (BD Biosciences, Milan, Italy). Cells
were plated on a 100 mm dish in MyeloCult® medium
(StemCell Technologies, Vancouver, BC, Canada) in the
presence of 1 μM hydrocortisone sodium succinate and
1% antibiotics. They were maintained in a controlled
CO2 incubator with 37°C, 95% humidity, 5% CO2 with
medium change every three days and sub-cultured with
0.05% trypsin in PBS when they reached 80% - 90% ofconfluence. Morphological homogeneity of the cells were
noticed along subcultures. Cells from passages 2–6 were
used for all experiments. The primary cells from HCC
nodules were identified as CAF while cells from distant
non-tumoral tissues as NTF (non-tumoral fibroblast).
HCC cell lines
Human HCC cell lines HuH-7 (JCRB0403) and JHH-6
(JCRB1030) were obtained from the Japan Health Science
Research Resources Bank (HSRRB, Tokyo, Japan). HuH-7
cells were grown in DMEM medium (high glucose) and
JHH-6 in Williams’ E medium. Both media were supple-
mented with 10% FBS, 1% L-glutamine, and 1% antibi-
otics. All cells were maintained at 37°C in a humidified 5%
CO2 incubator and were routinely sub-cultured with
0.05% trypsin in PBS when they reached 85% - 95%
confluence.
Flow cytometry and immunofluorescence
The presence of surface marker antigens was detected
using antibodies CD90/THY1 (Stem Cell Technologies,
Vancouver, BC, Canada), CD133/PROM1, CD45 (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany), CD44
(Abcam, Cambridge, UK), and STRO-1 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA). After detach-
ment, at least two million cells per mL were incubated
with specific first antibodies for 60 minutes on ice in the
dark. After two washings with PBS containing 0.5% bovine
serum albumin (BSA), when necessary, the cells were
incubated with fluorescence-conjugated secondary anti-
body for 60 minutes on ice in the dark. Flow cytometric
analysis was performed immediately in a FACSCalibur
flow cytometer (Becton Dickinson, NJ, USA). Ten thou-
sands events were analysed per sample.
The presence and localization of the proteins CD90,
CD44, Vimentin/Vim (Abcam), and alpha smooth muscle
actin/αSMA (Dako, Glostrup, Denmark) were visualized
with immunofluorescence using fluorescence microscope
Leica DM2000 (Leica Camera AG, Solms, Germany). The
nucleus of the cells was stained with Hoechst 33342 dye
(Sigma-Aldrich).
Total RNA isolation and reverse transcription
Total RNA was extracted using TriReagent (Sigma–
Aldrich) according to the manufacture’s protocol. RNA
was quantified at wavelength 260 nm in a DU®730 spec-
trophotometer (Beckman Coulter, Fullertone, CA, USA)
and RNA purity was evaluated according the MIQE
guidelines [7] by measuring the ratio A260/A280 with
an appropriate purity value between 1.8 and 2.0. The
integrity of RNA was assessed on standard 1% agarose/
formaldehyde gel. Reverse transcription of 1 μg of total
RNA was done using iScript cDNA synthesis Kit (Bio-Rad
Laboratories, Hercules, CA, USA).
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chain reaction (RTqPCR)
RTqPCR was performed according to the iQ SYBR
Green Supermix protocol. PCR amplification was carried
out in a 15 μL reaction volume containing 25 ng of
cDNA, 1x iQ SYBR Green Supermix, and 250 nM gene
specific sense and anti-sense primers and reaction was
run on a Bio-Rad iQ5 real-time PCR detection system
(IQ5 software version 3.1; Bio-Rad Laboratories), together
with reference genes RNA18S and β-actin (ACTB). Cyc-
ling parameters were determined and analyzed using the
Pfaffl modification of ΔΔCt equation with taking account
to the efficiency of the reaction [8,9]. The primers for
PCR were designed using software Beacon Designer
Version 7.9 (Premier Biosoft International, Palo Alto,
CA, USA). Primer sets were built across two exons to
avoid the contamination of genomic DNA. Nucleotide
BLAST was performed to check the specificity of the
sequences. Melting curve analysis and agarose gel elec-
trophoresis were carried out to assess the size of the tem-
plate products. The list of the primers sequences was
listed in Supplemental File (Additional file 1: Table S1).
Control for of primers: total RNA extract from IHH
cells for CD90; HuH-7 cells for CD133 [10,11]; Jurkat
cells for CD34; and HCC tissues and blood samples
for CD44, CD45, CD29, CD31, CD105, CD166, CD11B,
CD13, CD19, CD29, and CD79.
Clonogenic assay
The clonogenic capacity of the CAF in a 3-dimensional
anchorage-independent matrix was performed by growing
the cells at low density of 5000 cells/mL in 67% Matrigel
(BD Biosciences) in growth medium without serum on a
12-well cell culture plate. The clones were observed under
light microscope every three days (Nikon Eclipse TS100,
Nikon Instruments, Campi Bisenzio, Italy).
Trans-differentiation: adipogenic, osteogenic, and
pancreatic
For adipocyte differentiation, cells were plated in AdipoDiff
medium (Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany) for 3 weeks with medium change every 4 days.
The accumulation of fat deposit was stained using Nile
Red, a specific intercellular lipid staining, and the up-
regulation of gene PPARG (peroxisome proliferator-
activated receptor gamma) was quantified using RTqPCR.
For osteoblast differentiation, cells were plated in OsteoDiff
medium (Miltenyi Biotec) for 2 weeks. Alkaline phosphat-
ase activity was detected using Sigma Fast BCIP/NBT sub-
strate (Sigma-Aldrich) according to the manufacture’s
protocol. The up-regulations of bone-specific genes were
quantified using RTqPCR. The protocol for pancreatic
cells differentiation was performed according previous
reports in the presence of 10 mM nicotinamide [12,13].The identification of cells was performed using RTqPCR
on gene somatostatin (SST) and gastric inhibitory poly-
peptide (GIP). Direct DNA sequencing was carried out
to confirm the result (automated sequencer ABI Prism
3500xl genetic analyser, Applied Biosystems, Monza,
Italy).
Co-culture with HCC cells
A total 50,000 cells/mL of CAF were co-cultured to-
gether with 100,000 cells/ml of HuH-7 and JHH-6 cells
for 7 days in a 6-well plate of Transwell system (Corning
Costar, Milan, Italy). The alteration of tumor promoting
factors was evaluated by way of RTqPCR. For compari-
son, co-culture between NTF and both HCC cell lines
was also performed in the similar condition. The experi-
ment was conducted in duplicates in two independent
sets.
Xenograft assay
Male 7 weeks athymic nude (Foxn1(nu/nu)) homozygotes
and NOD/SCID (NOD.CB17-Prkdcscid/NCrHsd) mice
for in vivo xenotransplantation studies were obtained from
Harlan Laboratories, Srl (Udine, Italy). All animals were
maintained in the animal facility of the University of
Trieste. After detachment, CAF was suspended in 100 μL
cold PBS and placed in ice. A total of 50,000 to 1 million
cells were injected subcutaneously into abdomen of the
nude mouse in duplicates or orthotopic in the liver of
NOD/SCID mice. Viability of the cells was checked by try-
phan blue staining dye after injection. The xenotransplan-
tated mice together with control were observed for four
months after injection. Mouse body weight was measured
every week. Serum alanin transferase (ALT) and aspartate
transferase (AST) levels on sacrifice day were measured
by photometric enzymatic test (Cobas, Roche, Mannheim,
Germany).
Statistical analysis
Students’ t test was performed for statistical comparison
between groups using software InStat Version 3.05
(GraphPad Software, Inc., La Jolla, CA, USA). Statistical
significance was set to p < 0.05.
Results
Morphology and characterization of the cells
Primary cells from HCC (CAF) and from cirrhotic tissue
(NTF) were obtained. All cells showed fibroblastic-like
morphology and they had the ability to form clonal col-
onies after plating in low density. The presence of sur-
face markers proteins was detected by flow cytometry
and immunofluorescence. CAF showed higher percent-
ages of antigens CD90 and CD44 (52 ± 27% and 59 ±
22%, respectively) as compared to NTF (37 ± 28% and
74 ± 12%), however the differences were not statistically
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and STRO-1 were either negative or very low expressed
(Figure 1A).
The localizations of positive proteins CD90, CD44,
Vim, and αSMA were visualized by immunofluorescence.
As expected, CD90 and CD44 proteins were mainly local-
ized on the cell membrane while αSMA and Vim in the
cytoplasm (Figure 1B). When we compared the mRNA
expression of the αSMA (ACTA2), we observed that
ACTA2 expression was higher in CAF compared to NTF,
but less noticeable for VIM (Figure 1C).
To assess the clonogenic capacity of the CAF as one of
the characteristics of stem cells, CAF was grown in a
3-dimensional anchorage-independent matrix in Matrigel.Figure 1 The phenotypes of primary cells CAF and NTF. A. Flow cytom
CD90 and CD44, and the negativity for CD133, CD45, and STRO-1. Black gra
cells and localization of positive proteins CD90, CD44, αSMA, and Vimentin
(ACTA2) in CAF and NTF. VIM and ACTA2 mRNA relative expressions were n
capacity of the CAF in Matrigel. Scale bar, 100 μm.As shown on Figure 1D, a single cell formed a colony
three days after plating.
The presence of other cell markers was identified using
RT-PCR, based on the consensus for the mesenchymal
stem cells (MSC) and previous reports of multipotent
hepatic stem cells [12,14]. As expected, qualitative PCR
result showed that both CAF and NTF were positive for
MSC markers CD90, CD44, CD29, CD13, CD105 and
CD166, and negative for hematopoietic cells markers
CD34, CD117, and CD45 (Table 1).
Adipogenic, osteogenic, and pancreatic trans-differentiation
In total, nine primary cells CAF and NTF were sub-
jected to adipogenic, osteogenic, and pancreatic in vitroetric analysis of surface marker proteins showed the positivity for
ph: control, White graph: positive expression. B. Morphology of the
. Scale bar, 100 μm. C. mRNA expressions of vimentin (VIM) and αSMA
ormalized to reference genes RNA18S and ACTB. D. 3D clonogenic
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entiation, by using Nile Red staining we observed lipid
depositions in cytoplasm in five out of six samples in-
duced (83%), in both CAF and NTF. However, a signifi-
cant PPARG mRNA up-regulations was noticed only in
NTF differentiation, with the mean increase of 2.31 ± 0.29
fold compared to basal level (p < 0.05). Induced CAF
did not show an increment in PPARG mRNA expres-
sion (Figure 2A-B).
In osteogenic differentiation, induced CAF and NTF
were positive for alkaline phosphatase staining. CAF and
NTF showed similar tendencies on the regulation of
bone-specific genes, with clear up-regulations of bone
sialoprotein (IBSP), osteocalcin (BGLAP) and osteopon-
tin (OPN) and down-regulations of osteonectin (ON)
and osteoprotegerin (OPG) (p < 0.05) (Figure 2C-D).
When CAF and NTF were subjected to trans-differentiation
into pancreatic cells with the presence of 10 mM nicotina-
mide, induced CAF and NTF showed a clear up-
regulation of GIP with the means of mRNA increase
of 3.3 ± 2.0 fold and 7.9 ± 10.1 fold, respectively. More-
over, SST mRNA was found to be strongly increased after
the induction. DNA sequencing confirmed the specificity
of SST DNA sequence (Figure 2E-G).
Co-culture study
To investigate the difference between CAF and NTF in
hepatocarcinogenesis and to explore the cross talk be-
tween these cells with HCC cells, a co-culture study in a
Transwell system was performed. The HuH-7 and JHH-6Table 1 The genotypes of the primary cells
CAF NTF
+ - + -
MSC requirement CD90* CD11B* CD90* CD11B*
CD44 CD14* CD44 CD14*
CD29* CD19* CD29* CD19*
CD13 CD79* CD13 CD79*
CD105* CD117 CD105* CD117
CD166 CD34* CD166 CD34*
CD45* CD45*
Mesenchymal marker ACTA2 ACTA2
VIM VIM
Pluripotency markers OCT4 OCT4
SOX2 SOX2
Reference 18S 18S
ACTB ACTB
The mRNA analysis by RT-PCR of consensus markers of MSC, mesenchymal
activation, and pluripotency factors. + = positive expression, − = negative
expression. *The reference standard based on the Mesenchymal and Tissue Stem
Cell Committee of the International Society for Cellular Therapy [14].HCC cell lines were chosen to represent well- and poor-
differentiated HCC cells, respectively. mRNA analysis
showed that in basal condition, both CAF and NTF
expressed higher level of fibroblast activated protein
(FAP), ACTA2, and collagen type 1 (COL1) compared to
those of HuH-7 and JHH-6 (p < 0.01 for all genes; data
not shown).
After co-culture, we observed a significant effect of the
presence of both CAF and NTF in HCC cell lines. In the
presence of the CAF, the up-regulations of TGFB1 and
FAP were observed in both HCC cell lines (p < 0.05), a
slight up-regulation of ACTA2 was observed in HuH-7.
On the other hand, the presence of HuH-7 cells increased
the expressions of ACTA2 and COL1 in CAF, while JHH-6
cells did not (Figure 3A).
In contrast, we noticed clear decrease of tumor sup-
porting genes in HCC cells upon co-culture with the
NTF with the exception of the increases of FAP and
VIM in JHH-6. The mRNA expressions of CTGF, COL1,
E-cadherin (CDH1), and N-cadherin (CDH2) were down-
regulated in both HCC cell lines, while TGFB1 (p < 0.05),
ACTA2, and integrin β1 (CD29) were down-regulated
in HuH-7. In parallel, the presence of HCC cells up-
regulated the expressions of CTGF (p < 0.05), VIM,
COL1, and CD29 of the NTF. The expressions of TGFB1,
CDH1, and CDH2 of the NTF were up-regulated after
co-culture with JHH-6, a poor-differentiated HCC cell
line (Figure 3B).
Xenograft assay
Two CAFs were subjected to xenograft assay. The viabil-
ity of the cells was more than 95%. Four months after
subcutaneous injection in nude mice, the serum level of
ALT and AST of xenografts were slightly increased com-
pared to control (102 ± 23 IU vs. 77 ± 9 IU for ALT and
23 ± 2 IU vs. 17 ± 1 IU for AST) even though no tumor
nodules were observed. Orthotopic injection in NOD/
SCID mice resulted in the appearance of nodules in the
liver as well as in the lung and thymus. Cultured primary
cells of the nodules and the injected sites expressed
liver-specific markers ALB and AFP, including those of
human, as confirmed by DNA sequencing with reference
to DNA sequences of the CAF (Figure 4). However, we
could not notice the human CD90 protein. The positiv-
ity of human and murine genes of xenograft models is
listed on Table 2. No difference in body weight of all ani-
mals was noticed (data not shown).
Discussion
We report on the presence of CAF and NTF populations
with the characteristic of MSC in human hepatic tissues
obtained from HCC patients. The CAF and NTF were
negative or low expressed for the markers of endothelial
(CD31) and hematopoietic cells (CD34, CD45). They
Figure 2 Cells-directed in vitro differentiation of the CAF and the NTF. A-B. Adipogenic differentiation. Nile Red staining of lipid deposition
(arrow indicated) in the cytoplasm (A). RTqPCR result showed the mean of PPARG gene regulation (B). C-D. Osteogenic differentiation. Alkaline
phosphatase staining of macro- (upper panel) and microscopic visualization (lower panel). Scale bar, 100 μm (C). RTqPCR result of osteogenic
differentiation genes osteocalcin (BGLAP), bone sialoprotein (IBSP), osteopontin (OPN), osteoprotegerin (OPG) and osteonectin (ON) (D). E-G.
Endodermic differentiation. The qualitative result of the induction of somatostation (SST) and gastric inhibitory protein (GIP) using gel electrophoresis
(E). RTqPCR result of endodermic differentiation genes showed an induction/up-regulation of SST and GIP. NIC = nicotinamide. The target mRNA
expression was normalized to reference gene β-actin (F). Confirmation by DNA sequencing of human SST. SST_HCC3 = DNA sequences of
SST from induced CAF, NM_001048.3 = reference DNA sequences from GenBank (G). For RTqPCR data, basal expression was considered as
1.00, target mRNA expressions were normalized to reference genes RNA18S and ACTB. Scale bar, 100 μm. *p < 0.05.
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capacity to form colonies on plastic surface, and for CAF
in three-dimensional matrix, indicating its anchorage-
independent capacity and clonogenicity. The morphologicand phenotypic characteristics of the cells were main-
tained during subcultures.
Previously, Herrera et al. reported the isolation of the
multipotent hepatic liver stem cells (HLSC) from normal
Figure 3 Co-culture study between the primary cells and the HCC cell lines HuH-7 and JHH-6. A. Cross-talk between the HCC cells lines
and the CAF. B. Cross-talk between the HCC cells lines and the NTF. Target mRNA expression was normalized to reference genes RNA18S and
ACTB. CTRL = cells control without co-culture (=1.00). Target mRNA expressions were normalized to reference genes 18SRNA and ACTB. *p < 0.05
compared to each control.
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nestin. They could be differentiated not only into meso-
dermal lineages, but also into endodermal lineage [12].
In this work, we induced both CAF and NTF into meso-
dermal lineage (adipocytes and osteoblasts) and endoder-
mal lineage (pancreatic cells). After adipogenic induction,
lipid deposition in cytoplasm was clearly noticeable, ac-
companied by the up-regulation of PPARG, a master regula-
tor of adipocyte differentiation, in the NTF. After osteogenic
induction, the cells were positive for alkaline phosphatase
staining as well as the up-regulations of bone-specific
genes. Our data is in line with a previous study by Cesselli
et al. that the multipotent adult stem cells from diseased
liver cultured in osteogenic medium became positive to
von Kossa staining specific for bone differentiation and
expressed osteocalcin [6].
To investigate whether the cells can be differentiated
into not only similar mesenchymal lineage but also more
advanced into endodermal lineage, we induced the cells
into pancreatic cells. After induction, we observed the in-
duction of SST, markers for δ cell, and the up-regulation
of GIP, a member of glucagon, marker of α cell. However,
the expression of insulin, a marker for β cells of pancreatic
islet, was either absent of too low to be detected, at leastat mRNA level. One possible explanation is that these
cells were derived from cirrhotic and HCC tissues and
their multipotent capacity might be more restricted com-
pared to that of normal HLSC. Both phenotype and cap-
acity of these cells are in agreement with the consensus of
the Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy [14,15]. In par-
ticular, they showed plastic adherence in standard culture
condition, expression of CD105 and CD90, but not CD45
and CD34, and the potency to differentiate into mesen-
chymal lineage in vitro.
From the trans-differentiation data, we found that
both CAF and NTF had comparable potential to be in-
duced into various cell types, even though the plasticity
of the NTF was higher than the CAF. To understand
their intrinsic difference in hepatocarcinogenesis, we
performed a co-culture experiment with HCC cell lines
with different degrees of differentiation, in a Transwell
system. We observed that the presence of the CAF in-
creased the expression of several genes involved in
tumorigenesis in HCC cells. The expression of TGFB1
was increased, particularly in HuH-7, and a very strong
up-regulation was observed for the FAP in both HCC
cell lines.
Figure 4 Xenograft assay of the CAF. A. Tissue mass in the liver and lung of the NOD/SCID mouse following orthotopic injection of the CAF
from HCC. Arrow indicates nodules. B. Primary cells of the nodules in the orthotopic xenografts. Scale bar, 100 μm. C. The positivity of genes in
the xenograft primary cells. H = hepatic, L = lung, C + H = positive control human (human liver), C + M = positive control mouse (mouse liver).
Gene 18S is homolog for human and mouse species. D. DNA sequencing of human AFP of primary cells obtained from the lung of xenograft.
REF_AFP = DNA sequences of AFP genes from injected CAF, XG_AFP = DNA sequences of AFP genes from primary cultures of xenograft,
NM_001134.1 = reference DNA sequences from GenBank.
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apparent in the NTF, while the presence of the NTF
down-regulated the factors of HCC. The presence of
HCC cells induced a significant up-regulation of CTGF,
as well as VIM, COL1, CDH2, and CD29, markers for
mesenchymal phenotypes. This result was in accordance
with previous data observed by Mazzocca et al. that
HCC invasive cells produced high level of CTGF and
they generated tumors with high stromal component
in vivo [4]. The up-regulation ACTA2 of the NTF in the
presence of HuH-7 is also in agreement with the previ-
ous report on the trans-differentiation of the PTF intoTable 2 The positive expression of human and mouse genes
Strain Injection site n Nodule
Nude mice Subcutaneous 3 N/D
NOD/SCID mice Intrahepatic 2 liver and lu
Human and mouse genes positivity were detected using RT-PCR on xenograft tissuCAF-myofibroblast in the presence of conditioned medium
of HuH-7, even though in our experimental set we did not
add the LPA [5]. In this study, the extent of the mRNA ex-
pressions in the NTF was higher in the presence of the
poor-differentiated HCC cells JHH-6 compared to well-
differentiated HuH-7 cells. These data support our con-
clusion on the mutual cross talk of the CAF, the NTF, and
the cancer cells.
Yang et al. had demonstrated that CD90 cells isolated
from primary HCC induced tumor and lung metastasis
after orthotopic injection to SCID/Beige mice, indicating
the CD90+ cells as a marker of cancer stem cells (CSC)of the xenograft tissues
Human genes + Mouse genes +
ALB, AFP, Actin, 18S Afp, Actin, Gapdh, 18S
ng ALB, AFP, Actin, 18S Afp, Alb, Actin, Gapdh, 18S
es. Species specificity was checked using BLAST of NCBI. N/D: not detectable.
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tion of the CAF expressed CD90+ failed to induce tumor
in nude mice four months after injection. However,
orthotopic injection in the liver of NOD/SCID mouse
induced mass in the liver and the lung. Interestingly, we
noticed the presences of human ALB and AFP in the
primary cells obtained from the lung mass. We assumed
that the CAF were able to enter into circulation and
interact with resident tissue environment, this indirectly
supported our co-culture data in vitro. However, we did
not found cells positive for human CD90 and CD44 in
both liver and lung tissue. Therefore, although this initial
in vivo data is important, further studies must be con-
ducted to prove this interaction.
The negativity of human HCC after injection might in-
dicate either different function of CD90 cells population
in HCC or the presence of several different populations
of CD90 phenotype. We had recently reported that the
CD90 was up-regulated in liver cirrhosis and HCC com-
pared to normal tissue [17] and data from Yamashita et al.
had shown that the tumorigenicity of the CSC CD90+ cells
might appear in the late stages of hepatocarcinogenesis
with the preference to HBV-related HCC [18]. In our study,
none of our CAF was derived from HBV-related HCC and
the tissues were obtained from early stage of the disease
undergoing partial hepatectomy. It is possible that it might
be one of the reasons of this discrepancy, even though we
are not in the position to demonstrate this point further.
Although the origin of CAF in HCC is still controversial,
our result showed that CAF was able to differentiate into
other cell types and to circulate to other organs, one of
the characteristics of mesenchymal or stromal stem cells.
On the other hand, CAF could be also derived upon a
paracrine mechanism between multipotent NTF and
HCC cells. Further studies will be essential to demonstrate
the plasticity and mobility of resident fibroblasts in normal
liver as well as in the progression of liver disease.
Conclusion
In conclusion, our data provides clear evidence of the plas-
ticity of the stem cells-like CAF and NTF isolated from
HCC and liver cirrhosis in the process of hepatocarcino-
genesis and metastasis. These cells mutually interact with
HCC cells and deregulate important tumor promoting fac-
tors. Their trans-differentiation flexibility may induce a
switch from normal to cancerous microenvironment.
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